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ABSTRACT 
IMMUNOREGULATION OF LIVER REGENERATION BY THE  
ARYL HYDROCARBON RECEPTOR: ROLE OF LYMPHOCYTES AND 
INTERFERON-GAMMA 
 
by 
 
Christopher John Horras 
 
Boise State University, 2011 
Under the Supervision of Dr. Kristen A. Mitchell, Ph.D. 
 
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a persistent environmental 
contaminant that elicits toxicity by activating the aryl hydrocarbon receptor. The toxic 
effects associated with TCDD exposure include immunotoxicity and dysregulated cell 
cycle control, although the mechanisms are poorly understood. A previous report 
indicates that exposure to TCDD suppresses hepatocyte proliferation in a mouse model of 
liver regeneration induced by 70% partial hepatectomy (PH).  Based on reports that liver 
regeneration is negatively regulated by interferon (IFN)-γ produced by activated natural 
killer (NK) cells, along with the well-established immunotoxic effects of TCDD in other 
model systems, we hypothesized that TCDD treatment attenuates liver regeneration by 
enhancing NK cell activation and IFN-γ production in the regenerating liver. We also 
considered the effects of TCDD on natural killer (NK) T and T cells, which are capable 
of producing IFN-γ as well. Mice were treated with TCDD (20 µg/kg) one day prior to 
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surgical PH. Hepatocyte proliferation in the remnant liver was measured based on the 
incorporation of a thymidine analog, bromodeoxyuridine. Lymphocytes were collected 
from the spleen and remnant liver and analyzed by flow cytometry. IFN-γ was measured 
by intracellular staining followed by flow cytometry. Consistent with other reports, we 
found that TCDD treatment suppressed hepatocyte proliferation in the regenerating liver 
by 50-80%. However, contrary to our hypothesis, exposure to TCDD had no effect on the 
number of lymphocytes in the spleen or liver after PH, nor did it increase IFN-γ+ 
production by lymphocytes in the regenerating liver. Moreover, exposure to TCDD did 
not increase the number of NK and NKT cells expressing CD69, an early activation 
marker. To determine the relevance of NK cells to the TCDD-mediated suppression of 
liver regeneration, mice were treated with an α-asialo-GM-1 antibody to deplete NK cells 
prior to TCDD administration and PH. Depletion of NK cells did not restore hepatocyte 
proliferation in TCDD-treated mice, indicating that NK cells are not required for the 
attenuation of liver regeneration by TCDD.  Hence, exposure to TCDD suppresses in vivo 
hepatocyte proliferation by a mechanism that does not involve NK cells or enhanced 
production of IFN-γ.  
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containing compounds resulted in the formation of TCDD (Young, Thalken, & Harrison, 
1979). These herbicides were then used to destroy unwanted vegetation in agricultural 
operations throughout the world. Such widespread use resulted in the persistent presence 
of TCDD throughout the environment, where the half-life ranges from months to years, 
depending upon the medium of contamination (Mukerjee, 1998). Although herbicides are 
now regulated to avoid further TCDD contamination, the persistence of TCDD, due to its 
resistance to biodegradation, has led to a long-term and potentially permanent presence of 
this pollutant in the environment (Kao, Chen, Liu, & Wu, 2001). 
Several infamous environmental disasters culminated in the release of large 
concentrations of TCDD into the environment in a relatively short period of time 
(Freeman, Hileman, & Schroy, 1986; Lakshman, Campbell, Chirtel, & Ekarohita, 1985; 
Reggiani, 1978). Of these disasters, the use of the defoliant, Agent Orange, in the 
Vietnam War is the most well known. Agent Orange, like other defoliating herbicides, 
was unintentionally contaminated with TCDD during the manufacturing process. The 
United States military used Agent Orange to clear foliage from the jungle landscape in 
Vietnam as a tactical maneuver. Throughout this period, the United States military 
deposited large amounts of TCDD into the Vietnamese environment, resulting in the 
exposure of multitudes of U.S. and Vietnamese soldiers, along with Vietnamese civilians, 
directly to TCDD (Lakshman et al., 1985). 
Currently, TCDD is primarily produced as a result of industrial processes that 
involve chlorine-containing compounds, such as the bleaching of pulp in paper 
production and the incineration of municipal waste (Cummings, Korb, & Evans, 1987; 
Lebel, Williams, & Benoit, 1992). A significant source of TCDD production in the U.S. 
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is the incineration of medical refuse (Thornton, McCally, Orris, & Weinberg, 1996). This 
process results in the production of TCDD as various chlorine-containing plastics are 
heated. The TCDD is then released into the atmosphere when combustion fumes are 
emitted. Atmospheric TCDD then settles onto various terrestrial, aquatic, and marine 
environments and bioaccumulates in the food chain. While acute, high-level human 
exposure to TCDD has resulted from environmental disasters, chronic low-level human 
exposure results from the consumption of contaminated food products. Because it is 
lipophilic, TCDD can be stored long-term in fat tissue, and can be released as a result of 
fat metabolism (Travis & Hattemerfrey, 1991). 
Information about TCDD toxicity in humans is primarily derived from 
epidemiological studies of human exposure during industrial and environmental disasters; 
however, these studies are inherently limited due to a lack of appropriate controls and a 
multitude of confounding variables. Consequently, the toxic endpoints of TCDD 
exposure in humans, while well documented, remain contentious (White & Birnbaum, 
2009).  Hence, in vitro and rodent models have been used extensively to study TCDD 
toxicity. In rodents, TCDD treatment elicits a multitude of toxic effects including 
modulation of cell cycle progression, immunotoxicity, developmental toxicity, 
reproductive toxicity, cachexia (wasting syndrome), and cancer promotion (Abbott & 
Birnbaum, 1991; Chastain & Pazdernik, 1985; Gottlicher & Wiebel, 1991; Hanberg, 
Hakansson, & Ahlborg, 1989; Huff, 1992; Neubert, Krowke, Chahoud, & Franz, 1987; 
Rozman, 1984; Wolfle, Marotzki, Dartsch, Schafer, & Marquardt, 2000). Interestingly, 
TCDD has also been shown to exert protective effects against certain types of cancer 
(Biegel & Safe, 1990). These effects are diverse, tissue specific, and have not been 
  
explained by a common mechanism of TCDD toxicity to this point. As a result, work 
remains to be done to uncover the risks to human health posed by TCDD exposure.
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Whitlock, 1996).  In particular, the vascular development in AhR-null mice is retarded, 
resulting in anatomical malformations (Schmidt, Su, Reddy, Simon, & Bradfield, 1996). 
This is the case in the developing liver where absence of the AhR results in a patent 
ductus venosus, an incomplete closure of the liver vasculature. The resulting liver is 50% 
smaller than wild type livers and displays a spectrum of defects (Schmidt et al., 1996). 
While AhR null mice are surprisingly viable, it is apparent that the AhR is necessary for 
proper development of the liver.  
While the endogenous ligand and physiological function of the AhR remain a 
mystery, this receptor displays promiscuity in binding to xenobiotic ligands (Savouret, 
Berdeaux, & Casper, 2003). TCDD is the most potent of the xenobiotic AhR ligands due 
to its high binding affinity (Kd = approximately 5nM in humans), and the AhR is 
required for the toxic effects of TCDD to be manifested (Bunger et al., 2003; Harper, 
Prokipcak, Bush, Golas, & Okey, 1991; Vorderstrasse, Steppan, Silverstone, & Kerkvliet, 
2001). It is well established that cells, as well as mice, that lack a functional AhR do not 
display the typical endpoints of TCDD toxicity (Fernandez-Salguero, Hilbert, Rudikoff, 
Ward, & Gonzalez, 1996; Schmidt et al., 1996). 
The classical mechanism of AhR activation by TCDD is widely accepted (Figure 
1.3) (Fuji-Kuriyama & Kawajiri, 2010; Mitchell & Elferink, 2009). TCDD enters cells by 
simple diffusion due to its lipophilic nature. Prior to ligand binding, the AhR resides in 
the cytosol accompanied by the following chaperone proteins: two molecules of heat-
shock protein 90 (hsp90), an immunophilin analogue protein (AIP), and a c-Src protein 
kinase (Carver & Bradfield, 1997; Chen & Perdew, 1994; Enan & Matsumura, 1996). 
Once in the cytosol, TCDD binds to the AhR, and the chaperone proteins dissociate from 
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the complex. The AhR then translocates to the nucleus, where it is joined by the AhR 
nuclear translocator (Arnt) (Elferink, Gasiewicz, & Whitlock, 1990; Gasiewicz, Elferink, 
& Henry, 1991; Ikuta, Eguchi, Tachibana, Yoneda, & Kawajiri, 1998). This complex is 
transcriptionally active and binds to DNA at dioxin response elements (DREs) (Elferink 
et al., 1990). DREs are stretches of DNA containing the core sequence 5’-GCGTG-3’ 
within the consensus sequence 5’-T/GNGCGTGA/CG/CA-3’ (Lusska, Shen, & 
Whitlock, 1993; E. S. Shen & Whitlock, 1992). Genes containing DREs include various 
xenobiotic-metabolizing enzymes, the archetype of which is Cyp1a1, which encodes the 
enzyme, cytochrome P4501A1 (Whitlock, 1999). The Cyp1a1 gene contains six DREs 
(Ma, 2001) and is regulated exclusively by the AhR, which makes it a sensitive and 
reproducible hallmark of AhR activation (Fukunaga et al., 1995). While many exogenous 
AhR ligands are metabolized by cytochrome P4501A1, TCDD is an exception, as it is not 
a substrate for this enzyme.  As a result, TCDD is not metabolically depleted and remains 
bound to the AhR for a sustained period of time (Fuji-Kuriyama & Kawajiri, 2010). In 
fact, the half-life of TCDD in mice is estimated at 10 days (Miniero, De Felip, Ferri, & di 
Domenico, 2001).  The phenomenon of sustained AhR activation is thought to contribute 
to the toxicity of TCDD.  
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Figure 1.3 Classical Mechanism of AhR Activation. TCDD diffuses across the cell 
membrane and binds to the AhR in the cytosol. The AhR is bound to chaperone proteins 
hsp90, immunophilin analogue protein (AIP), and c-Src prior to ligand binding 
(Whitlock, 1999).  Binding of TCDD to the AhR displaces the chaperone proteins, and 
the AhR translocates to the nucleus, where it binds to the AhR nuclear translocator 
(Arnt). This heterodimer is a transcriptionally active complex that binds to dioxin 
response elements (DREs) and modulates the transcription of target genes, resulting in 
changes in cell cycle regulation, apoptosis, metabolism, along with other processes. 
 
 
Cell Cycle Regulation by the AhR 
  
Increasing evidence demonstrates that the AhR regulates cell cycle progression in 
several types of cells, including hepatocytes (Gottlicher & Wiebel, 1991), lymphocytes 
(Laiosa et al., 2003), neuronal cells (Jin, Jung, Lee, & Kim, 2004), and keratinocytes 
(Ray & Swanson, 2003). The cell cycle is comprised of the following stages: G1, S, G2, 
and M (Alberts, 2010).  Cells in G1 have recently divided and are growing for another 
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division or for entry into quiescence. If the proper signals are present, a cell will progress 
from G1 into S-phase. In S-phase, the cell replicates its DNA in preparation for division. 
Following further signaling, the cell passes into G2, where it duplicates its organelles and 
produces components necessary for mitosis, the next stage. The cell then progresses 
through the stages of mitosis, and ultimately completes division into two identical cells in 
the final step called cytokinesis (Alberts, 2010). 
In rat 5L hepatoma cells, endogenous AhR activity is particularly important for 
transition through the G1/S-phase boundary, as AhR-deficient cells elicit a G1 arrest that 
is rectified upon reintroduction of a functional receptor (Ma & Whitlock, 1996). A 
similar cell cycle arrest is observed in 5L hepatoma cells treated with TCDD, which 
raises the intriguing possibility that transient, endogenous AhR activation promotes cell 
cycle progression. In contrast, sustained AhR activation by TCDD, a poorly metabolized 
exogenous agonist, impedes cell cycle progression (Barhoover, Hall, Greenlee, & 
Thomas, 2010; Gottlicher & Wiebel, 1991; Reiners, Clift, & Mathieu, 1999). Several 
studies demonstrate that the mechanism by which TCDD elicits an in vitro G1 arrest 
involves the AhR-mediated induction of p27Kip1 (Kolluri, Weiss, Koff, & Gottlicher, 
1999). p27Kip1, and the related protein p21Cip1, inhibit S-phase progression by blocking 
the activity of cyclin-dependent kinases that otherwise phosphorylate and inactivate the 
tumor suppressor, retinoblastoma protein (Rb) (Albrecht et al., 1998). Using a mouse 
model of liver regeneration induced by 70% partial hepatectomy (PH), it was found that 
TCDD treatment elicits a similar G1 arrest in hepatocytes in the regenerating liver. 
However, no overt changes in p27Kip1 or p21Cip1 expression were observed, raising the 
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possibility that the mechanisms by which TCDD elicits a G1 arrest in vivo are distinct 
from those mechanisms identified in vitro (Mitchell, Lockhart, Huang, & Elferink, 2006). 
Physiology of Liver Regeneration 
The PH model system is well established for studying mechanisms of in vivo cell 
cycle control (Fausto, Campbell, & Riehle, 2006).  Surgical removal of 70% of the liver 
results in coordinated proliferation of the remaining hepatocytes. While the precise 
mechanisms of liver regeneration are poorly understood (Michalopoulos, 2010), a 
working model divides the process into four phases: priming, progression, cell cycle, and 
termination (Michalopoulos, 2007). The priming phase occurs within the first 2-6 hours 
after PH and involves changes in the extracellular matrix and production of tumor 
necrosis factor (TNF)-α and interleukin (IL)-6, which leads to the STAT3-mediated 
expression of immediate early genes needed for hepatocytes to transition from G0 
(quiescence) to G1 phase of the cell cycle. The progression phase occurs as hepatocytes 
move into G1 of the cell cycle and is marked by increased expression of hepatocyte 
growth factor, epidermal growth factor, transforming growth factor, and inducible nitric 
oxide synthase (iNOS). The next step is the cell cycle phase, in which molecular signals 
permit the transition of hepatocytes from G1 to S phase. Cells subsequently progress 
through the cell cycle and proliferate continuously until the original liver mass is 
restored. Termination of hepatocyte proliferation presumably depends on an unidentified 
"stop" signal (Michalopoulos, 2010).  
Although the precise mechanisms that terminate hepatocyte proliferation remain 
unclear (Michalopoulos, 2007), one potential mechanism is the production of interferon 
(IFN)-γ by natural killer (NK) cells, which increase in number following PH (Vujanovic 
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et al., 1995). Presumably, resident NK cells in the liver are activated, proliferate, and 
produce IFN-γ, resulting in a hepatocyte cell cycle arrest. In addition, activated NK cells 
could potentially be recruited to the liver from the spleen (Figure 1.4). 
 
 
Figure 1.4 Potential Role of NK cells and IFN-γ in Attenuating Liver Regeneration. 
Immediately after PH, NK cells in the liver become activated, proliferate and produce 
IFN-γ.  IFN-γ binds to the IFN-γ receptor on hepatocytes (not shown), activating Stat1, 
leading to cell cycle arrest. Furthermore, NK cells may directly kill regenerating 
hepatocytes.  Finally, NK cells in the spleen may also become activated after PH and 
migrate to the liver (Ochi et al., 2004; Sun & Gao, 2004; Sun et al., 2006). 
 
 
NK Cells and IFN-γ 
 
The immune system utilizes antigen-specific (adaptive) and non-specific (innate) 
defenses that function together to defend an organism from invading pathogens and the 
progression of cancer. The adaptive branch of the immune system includes cells that 
demonstrate specificity in their defense functions, including the use of variable receptors 
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and antibodies for the elimination of antigens. The innate branch of the immune system 
includes cells and soluble factors that lack specificity for antigens. NK cells are one 
component of the innate immune system. They develop in the bone marrow from the 
lymphoid lineage of cells and reside primarily in the blood, spleen, and liver. While NK 
cells make up a small percentage of lymphocytes in the blood and spleen (<5%), the liver 
contains a relatively large population of resident NK cells, where they account for 10-
25% of all intrahepatic lymphocytes (Gao, Jeong, & Tian, 2008). In fact, recent reports 
emphasize the immunological nature of the liver due to a plethora of resident immune 
cells found here (Crispe, 2009; Gao et al., 2008; Racanelli & Rehermann, 2006). NK 
cells are responsible for general clearance of virus-infected cells and cancer cells and are 
activated by an array of cytokines, including IL-2 and IL-12, both of which are produced 
by macrophages, another facet of the innate immune system. NK cells destroy cancerous 
and infected cells by FAS-dependent apoptosis signaling, by becoming directly cytotoxic, 
and by producing IFN-γ (Goldsby, Kindt, Osborne, & Kuby, 2000). 
IFN-γ is an inflammatory cytokine recognized for its antiviral and 
immunomodulatory properties.  Also known as type II interferon, IFN-γ exerts its actions 
by binding to the IFN-γ receptor (IFNGR), a heterodimeric transmembrane protein 
expressed on a variety of cell types, including regenerating hepatocytes (Billiau & 
Matthys, 2009; Nagao et al., 2000; Valente et al., 1992; Volpes et al., 1991).  The IFNGR 
is comprised of a constitutively expressed alpha chain (IFNGR1), which contains a 
ligand-binding domain and an inducible, non-ligand-binding beta chain (IFNGR2) (Farrar 
& Schreiber, 1993).  IFN-γ interacts with IFNGR1, which initiates the association of 
IFNGR1 with IFNGR2 and subsequent phosphorylation of JAK1 and JAK2 kinases.  
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Activated JAK kinases phosphorylate the cytoplasmic tails of IFNGR1 subunits, 
providing a docking site for Stat1, a member of the signal transducer and activator of 
transcription (Stat) family of transcription factors.  Stat1 becomes phosphorylated and 
dissociates from IFNGR1, forms homo- or heterodimers, and translocates to the nucleus 
to modulate transcription of IFN-γ-responsive genes, including interferon regulatory 
factor (IRF)-1 (Ihle et al., 1994). IRF-1 is a transcription factor that binds to interferon-
sensitive response elements to drive the expression of an additional set of IFN-γ-
responsive genes, including those involved in apoptosis and cell cycle regulation (Ihle et 
al., 1994; Tamura, Yanai, Savitsky, & Taniguchi, 2008).  
Recent work has revealed a role for innate immunity in regulating liver 
regeneration (Dong, Wei, Sun, & Tian, 2007; K. Shen et al., 2008; Sun & Gao, 2004; 
Wei, Wei, Wang, Tian, & Sun, 2010). Studies indicate that NK cells increase in number 
and activity during liver regeneration following PH (Lai, Chen, & Chen, 1996). 
Additionally, the notion that IFN-γ, produced primarily by NK cells, negatively regulates 
regeneration is supported by observations that hepatocyte DNA synthesis is increased in 
the regenerating liver of mice that are nullizygous for the IFN-γ receptor, as well as in 
mice that were depleted of NK cells prior to surgery (Sun & Gao, 2004). IFN-γ may 
inhibit hepatocyte proliferation in the regenerating liver through the Stat1-mediated 
induction of IRF-1 and p21Cip1, as administration of IFN-γ induced the expression of 
these proteins, as well as phosphorylated Stat1, within 4 h after PH. Moreover, treatment 
with IFN-γ in vitro inhibited cell proliferation of wild-type mouse hepatocytes but not 
STAT1-/-, IRF-1-/-, or p21Cip1-/- hepatocytes (Sun et al., 2006). 
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While previous reports have identified NK cells as the primary source of IFN-γ 
production during liver regeneration after PH (Sun & Gao, 2004), other lymphocyte 
types, including T cells and NKT cells, have also been reported to produce IFN-γ in other 
models (Dong, Zhang, Sun, Wei, & Tian, 2007; Komita et al., 2006; Miyagi et al., 2004; 
Otani et al., 1999). Murine NKT cells are a subset of T cells that possess an invariant T 
cell receptor (TCR), a transmembrane CD3 protein, and the NK cell marker, NK1.1. The 
NKT TCR recognizes CD1d antigen presentation molecules containing α-
galactosylceramide, a glycolipid found in a variety of infectious bacteria.  In contrast to 
NKT cells, murine NK cells lack a TCR and the CD3 transmembrane protein while 
expressing the NK1.1 surface marker (Bendelac, Savage, & Teyton, 2007).  The liver 
contains a relatively high concentration of NKT cells compared with other lymphoid 
organs, and murine NKT cells have been shown to increase in propensity and activation 
following PH (Minagawa et al., 2000). Taken together, these data support the notion that 
NK cells, NKT cells, and T cells all represent possible sources of IFN-γ that could 
negatively regulate liver regeneration after PH. 
TCDD Immunotoxicity 
TCDD is one of the most immunotoxic compounds known and displays a wide 
array of effects on various aspects of the immune system (Kerkvliet, 2009). Generally 
speaking, exposure to TCDD results in suppression of adaptive immune responses. 
However, TCDD treatment has also been shown to augment the innate immune response, 
including IFN-γ production, in several model systems (Knutson, Neff-LaFord, & 
Lawrence, 2003; Neff-LaFord, Teske, Bushnell, & Lawrence, 2007; Sugita-Konishi, 
Kobayashi, Naito, Miura, & Suzuki, 2003). Conversely, TCDD has been shown to 
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decrease IFN-γ in other model systems (Benson & Shepherd, 2011; Prell, Oughton, & 
Kerkvliet, 1995).  Reports of the consequences of TCDD treatment on NK cell activity 
are equally inconsistent (Funseth & Ilback, 1992; X. H. Wang, Zhou, Xu, Wang, & Lu, 
2009) yet provide evidence that these cells may indeed be modulated by exposure to 
TCDD. 
Hypothesis 
It has been previously demonstrated that TCDD treatment attenuates liver 
regeneration (Mitchell et al., 2006). The current study aims to elucidate a possible 
mechanism for this effect. Evidence from previous studies implicate NK cells in 
negatively regulating liver regeneration via IFN-γ production (Sun & Gao, 2004). 
Furthermore, TCDD treatment has been shown to modulate the innate immune response, 
including NK cell activity and IFN-γ production in other model systems (Benson & 
Shepherd, 2011; Funseth & Ilback, 1992; Prell et al., 1995; X. H. Wang et al., 2009). 
Based on these observations, we hypothesized that TCDD treatment attenuates liver 
regeneration by increasing the number of NK cells and enhancing IFN-γ production in 
the regenerating liver. The aims of the study were as follows: 
• Determine the effect of TCDD treatment on the number of NK, NKT, and T cells 
in the spleen and regenerating liver after PH. 
• Determine the effect of TCDD treatment on the production of IFN-γ by NK, 
NKT, and T cells in the regenerating liver. 
• Determine the effect of TCDD treatment on the number of activated NK, NKT, 
and T cells in the regenerating liver by assessing the expression of the early 
activation marker, CD69. 
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• Determine if TCDD-induced attenuation of liver regeneration requires the 
presence of NK cells. 
Experimental Design 
Figure 1.5 outlines the experimental design used to investigate the role of NK 
cells in the suppression of liver regeneration in TCDD-treated mice.  Mice were treated 
by oral gavage with 20 µg/kg TCDD or peanut oil vehicle. After 24 h, mice were 
anesthetized by continuous isoflurane inhalation, and three of the five liver lobes were 
surgically removed. To measure hepatocyte proliferation, mice were injected with 
bromodeoxyuridine (BrdU) two hours before euthanasia. BrdU is a thymidine analog and 
is incorporated into newly synthesized DNA. Mice were euthanized 0, 12, 24, 36, and 42 
h after PH.  Liver, spleen, and plasma were collected.  Lymphocytes were isolated and 
analyzed by flow cytometry.  Hepatocyte proliferation was measured using 
immunohistochemistry. In NK cell depletion studies, mice were treated with α-Asialo 
GM-1 (αASGM-1) antibody or PBS 24 h prior to TCDD or vehicle treatment. 
 
Figure 1.5 Experimental Design 
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CHAPTER II: MATERIALS AND METHODS 
Animal Treatment 
Female C57Bl/6 mice (7-8 weeks old; The Jackson Laboratory, Bar Harbor, ME) 
were housed in microisolators, maintained on a 12-h light cycle, and provided with free 
access to food and water. TCDD (Cambridge Isotope Laboratories, Andover, MA) was 
dissolved in anisole, diluted in peanut oil, and administered by oral gavage at 20 µg/kg 
bodyweight. Control mice received peanut oil that contained an equivalent amount of 
anisole. This dose of TCDD is not overly toxic (Pohjanvirta, Unkila, & Tuomisto, 1994) 
and represents the lowest dose at which consistent, reproducible suppression of liver 
regeneration was observed. The next day, mice were anesthetized with inhaled isoflurane, 
and PH was performed by surgically resecting 70% of the liver, as described elsewhere 
(Mitchell et al., 2006). To measure hepatocyte proliferation, mice were injected i.p. with 
50 mg/kg bromodeoxyuridine (BrdU; Sigma-Aldrich, St. Louis, MO) 2 h before 
euthanasia. For experiments in which NK cells were depleted, lyophilized rabbit α-
ASGM-1 antibody (Wako Pure Chemical Industries, Osaka, Japan) was resuspended in 2 
ml water and injected i.p. at 80 µl/mouse 24 h prior to administration of TCDD or 
vehicle. This volume of antibody was selected based on the manufacturer's 
recommendations. Based on FACS analysis using NK1.1 and CD3 antibodies, this 
treatment regimen effectively depleted NK cells for at least four days. All experiments 
were performed in compliance with the standards in place at the Boise VA Medical 
Center. 
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Immunohistochemistry 
Remnant liver tissue was fixed in Ultralight Zinc Formalin Fixative (Bi-Biomics, 
Nampa, ID) prior to being paraffin embedded and processed for immunohistochemical 
staining with a BrdU staining kit (Invitrogen, Carlsbad, CA). Briefly, 5-µm sections were 
incubated with a biotinylated BrdU antibody followed by avidin-conjugated horseradish 
peroxidase and the substrate 3,3-diaminobenzidine (DAB); tissue was counterstained 
with hematoxylin. To quantify hepatocyte proliferation, brown-stained (BrdU+) nuclei 
were counted in four separate fields (400X magnification) per animal and expressed as a 
percentage of the total number of nuclei. 
Splenocyte Isolation 
Spleens were harvested into ice-cold RPMI 1640 with 2.5% FBS and kept on ice 
throughout processing. Spleens were pressed between frosted microscope slides to 
prepare single-cell suspensions, and red blood cells were removed by hypotonic lysis. 
Cells were centrifuged at 350xg for 10 minutes at 4ºC, and the supernatant was discarded. 
Cells were resuspended in fresh media, and debris was settled and removed. Cells were 
then enumerated and stained for flow cytometry. 
Intrahepatic Lymphocyte Isolation 
Livers were perfused with ice-cold Hank’s Buffered Salt Solution (HBSS) 
containing 50 mM EDTA. The portal vein was cannulated, and the inferior vena cava was 
severed below the liver to allow blood outflow. Livers were then transferred to ice-cold 
RPMI 1640 with 2.5% FBS, minced into a slurry, and poured into a nylon cell strainer 
atop a 50-ml conical tube. The slurry was pressed against the cell strainer using the 
plunger end of a 10-cc syringe and washed repeatedly. Samples were centrifuged at 60xg, 
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1 minute, at room temperature with no brake; pellets containing hepatocytes were 
discarded. Samples were then centrifuged at 500xg, 10 minutes, at room temperature with 
high brake. Resulting pellets were resuspended in 10 ml of 37.5% isotonic Percoll in 
RPMI 1640 without FBS and centrifuged at 850xg, 30 minutes, at room temperature with 
no brake. Pellets were depleted of red blood cells by hypotonic lysis. Remaining 
lymphocytes were washed and resuspended in PBS containing 1% fetal bovine serum. 
Flow Cytometry 
Freshly isolated splenocytes and intrahepatic lymphocytes were incubated with Fc 
receptor block (BD Biosciences, San Jose, CA) for 10 minutes before staining with the 
following fluorochrome-conjugated antibodies purchased from BD Biosciences: NK1.1 
(PK136), CD3 (145-2C11), and CD69 (H1.2F3). Control cells were incubated with 
isotype-matched, fluorochrome-conjugated antibodies. To measure intracellular IFN-γ, 
cells were stained with antibodies against surface antigens, incubated with eBioscience 
Intracellular Fixation Buffer (eBioscience, San Diego, CA) for 30 minutes on ice then 
incubated with eBioscience Permeabilization Buffer for 5 minutes at room temperature. 
Cells were washed and incubated with an APC-conjugated α-IFN-γ antibody (XMG1.2, 
BD Biosciences) diluted in permeabilization buffer. Stained cells were analyzed on an 
Accuri C6 flow cytometer (Ann Arbor, MI). At least 50,000 events were collected from 
unpooled samples and analyzed using Accuri CFlow Plus software.  
Statistical Analysis 
Statistical analyses were performed using Prism (version 4.0a; GraphPad 
Software, San Diego, CA). Data were evaluated by two-way analysis of variance 
followed by a Bonferroni post hoc test to evaluate differences between TCDD- and 
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vehicle-treated groups. One-way analysis of variance was used to evaluate differences 
among time points within a single treatment group. Data were considered significantly 
different at p ≤ 0.05. 
Cell Percentage Graphs and Cell Number Graphs 
Throughout this thesis, changes in lymphocyte populations are depicted by graphs 
for both percentage and total number of cells. Absolute lymphocyte numbers were 
calculated from FACS data, and percentages of specific cell phenotypes were multiplied 
by lymphocyte numbers to yield the total number of cells. As a consequence, the trends 
in percentage graphs differ from the trends in graphs depicting the total number of cells. 
The total number of cells was considered the mechanistically relevant metric since the 
number of hepatocytes per liver did not vary widely, and the number of lymphocytes 
available to exert actions on hepatocytes was considered the most crucial factor.   
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CHAPTER III: RESULTS 
Exposure to TCDD Suppresses Hepatocyte Proliferation during Liver Regeneration 
To confirm the finding that exposure to TCDD elicits a G1 cell cycle arrest in 
hepatocytes in the regenerating liver, hepatocyte proliferation was measured based on 
incorporation of the thymidine analog, bromodeoxyuridine (BrdU), which is incorporated 
into newly synthesized DNA during S phase. In vehicle-treated mice, approximately 40% 
of hepatocyte nuclei were BrdU+ 36 and 42 h after PH (Figure 2.1A, B), which is when 
peak DNA synthesis occurs in the regenerating mouse liver (Mangnall, Bird, & Majeed, 
2003). In contrast, TCDD treatment reduced the percentage of BrdU+ nuclei by two- to 
five-fold, indicating that fewer cells in the regenerating liver had entered S-phase in these 
mice. 
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Figure 3.1 TCDD Treatment Suppresses Hepatocyte Proliferation after PH. Mice 
were treated with vehicle or TCDD 24 h before PH.  Mice were pulsed with BrdU and 
euthanized at the indicated times. A) Representative BrdU staining in the regenerating 
liver of vehicle- or TCDD-treated mice 36 hr after PH.  BrdU+ cells are identified by the 
dark brown (3,3’-diaminobenzidine-stained) nuclei (400X). B) Average percentage of 
BrdU+ nuclei (± SEM) in liver tissue from (n=3-6). *Significantly different from vehicle-
treated group at same time point (p ≤ 0.05). 
 
 
 
 
 
 
 
 
 
22 
 
 
 
TCDD Treatment Does Not Alter Lymphocyte Populations in the Spleen during 
Liver Regeneration 
The spleen represents an extrahepatic source of immune cells, such as NK cells, 
which may become activated to produce inflammatory cytokines or migrate to the 
regenerating liver (J. Wang, Xu, Zhang, Wei, & Tian, 2005). Hence, we investigated the 
consequences of TCDD on the size and cellular composition of the spleen during liver 
regeneration. Partial hepatectomy caused an increase in splenocyte number at 36 h 
(Figure 2.2A), and TCDD treatment did not alter this trend. Although NK cells comprise 
a small portion of splenocytes (Figure 2.2B, C), the number of NK cells in the spleen 
increased 36 h after PH (Figure 2.2D). TCDD had no effect on the number of splenic NK 
cells at any time point after PH.  
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Figure 3.2 TCDD Treatment Does Not Alter Lymphocyte Populations in the Spleen 
during Liver Regeneration. Mice were treated with vehicle or TCDD 24 h prior to PH 
and euthanized postoperatively at the indicated times. A) Average number of splenocytes 
(±SEM) from 3-9 mice per treatment group at each time point. B) Representative FACS 
histogram depicting populations of T cells, NKT cells and NK cells based on dual 
staining of splenocytes with NK1.1 and CD3 antibodies. C, D) Average percentage and 
number of splenic NK cells (± SEM) from 3-9 mice per treatment group at each time 
point. Results are representative of three separate experiments. *Significantly different 
from 0 h vehicle-treated mice (p ≤ 0.05). 
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Exposure to TCDD Does Not Increase the Number of Lymphocytes in the 
Regenerating Liver 
Based on reports that the number of NK cells in the liver increases following PH 
(Lai et al., 1996), we investigated the ramifications of TCDD exposure on lymphocyte 
populations in the regenerating liver. The total number of intrahepatic lymphocytes 
doubled 42 h after PH in both vehicle- and TCDD-treated mice (Figure 2.3A). NK cells, 
NKT cells, and CD3+ T cells were identified in the regenerating liver based on staining 
with anti-NK1.1 and -CD3 antibodies (Figure 2.3B). Numbers of intrahepatic NK and 
NKT cells increased after PH (Figure 2.3C). TCDD treatment did not alter the percent or 
number of NK cells in the liver at any time point tested but did suppress the expansion of 
NKT cells in the liver 42 h after PH.  Exposure to TCDD had no appreciable effect on the 
prevalence of CD3+ T cells in the liver (Figure 2.3C).  
 
 
 
25 
 
 
 
 
Figure 3.3 Exposure to TCDD Does Not Increase the Number of Lymphocytes in the 
Regenerating Liver. Mice were treated with vehicle or TCDD 24 h prior to PH and 
sacrificed postoperatively at the indicated times. A) Average number of intrahepatic 
lymphocytes (IHLs) per gram liver (± SEM). B) Representative FACS histogram 
depicting lymphocyte subpopulations in the liver of vehicle- and TCDD-treated mice 42 
hr after PH.  Freshly isolated IHLs were dual-stained with NK1.1 and CD3 antibodies. C) 
Average percentage and number NK cells, NKT cells, and T cells in the regenerating 
liver of vehicle- and TCDD-treated mice (± SEM).  Three to six mice were used per 
treatment group at each time point; results are representative of three separate 
experiments. *Significantly different from 0 h vehicle-treated mice (p ≤ 0.05). 
**Significant difference between vehicle- and TCDD-treated mice at same time point. 
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TCDD Treatment Does Not Increase the Activation of Intrahepatic Lymphocytes 
Activated NK cells and NKT cells are implicated in the inhibition of liver 
regeneration, and these lymphocytes have been shown to increase expression of the 
activation marker CD69 during regeneration (Dong et al., 2007; Dugan, Fullerton, Roth, 
& Ganey, 2011). We found that CD69 was expressed on a greater number of 
lymphocytes in the regenerating liver after PH (Figure 2.4A-C). This was observed at 42 
h for NK cells, 36 and 42 h for NKT cells, and at 42 h for CD3+ T cells. While TCDD 
treatment altered the percentage of CD69+ NK and NKT cells in the liver after PH, it did 
not alter the number of CD69+ NK, NKT, or T cells in the regenerating liver at any time 
point after PH.  
 
27 
 
 
 
 
Figure 3.4 TCDD Treatment Does Not Increase the Activation of Lymphocytes in 
the Regenerating Liver. Mice were treated with vehicle or TCDD 24 h prior to PH and 
sacrificed postoperatively at the indicated times.  Data represent average percentage and 
number of IHLs (A), NK cells (B), NKT cells (C), and CD3+ T cells (D) that express high 
levels of CD69. Data represent the average percentage and number (±SEM) of CD69+ 
IHLs (A), NK cells (B), NKT cells (C), and CD3+ T cell (D).  Three to six mice were 
used per time point in each treatment group. *Significantly different from 0 h vehicle-
treated mice (p ≤ 0.05). **Significant difference between vehicle- and TCDD-treated 
mice at same time point. 
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TCDD Treatment Does Not Increase IFN-γ Production by Lymphocytes in the 
Regenerating Liver 
Based on the well-established inhibitory effects of IFN-γ on hepatocyte 
proliferation (K. Shen et al., 2008; Sun & Gao, 2004; Sun et al., 2006; Wei et al., 2010), 
we tested the hypothesis that TCDD treatment increased IFN-γ production by 
lymphocytes in the regenerating liver. Flow cytometry was used to quantify IFN-γ-
producing lymphocytes in the regenerating liver of vehicle- and TCDD-treated mice 
(Figure 2.5A). Within 36 h after PH, the number of IFN-γ-producing lymphocytes in the 
liver increased 3-5 fold (Figure 2.5B).  Intracellular expression of IFN-γ was detected not 
only in NK cells (Figure 2.5C), but also in NKT and CD3+ T cells (Figure 2.5D and E); 
however, TCDD treatment did not enhance IFN-γ expression in any of these lymphocyte 
subpopulations.  
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Figure 3.5 TCDD Treatment Does Not Increase IFN-γ Production by Lymphocytes 
in the Regenerating Liver. Mice were treated with vehicle or TCDD 24 h prior to PH 
and sacrificed postoperatively at the indicated times. A) Representative FACS histograms 
depicting IFNγ+ staining profile in pooled cells left unstained or stained with an isotypic 
control antibody, as well as representative staining in IHLs isolated from vehicle- and 
TCDD-treated mice 36 h after PH. Graphs represent average percentage and number (± 
SEM) of IFN-γ+ IHLs (B), NK cells (C), NKT cells (D), and CD3+ T cells (E). 
*Significantly different from 0 h vehicle-treated mice (p ≤ 0.05). **Significant difference 
between vehicle- and TCDD-treated mice at same time point. 
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Depletion of NK Cells Does Not Ablate TCDD-Induced Attenuation of Liver 
Regeneration 
Previous studies have demonstrated that depletion of NK cells enhances liver 
regeneration (Sun & Gao, 2004; Sun et al., 2006), which underscores the potential for 
these cells to curtail hepatocyte proliferation in the regenerating liver. Hence, we 
surmised that if NK cells were essential to the suppression of liver regeneration by 
TCDD, then depletion of NK cells should abrogate the suppressive effects of TCDD on 
hepatocyte proliferation during regeneration. To this end, mice were depleted of NK cells 
by administration of α-ASGM-1 antibody prior to TCDD treatment and surgical PH. 
Treatment with α-ASGM-1 did not impact NKT or CD3+ T cell populations (Figure 
2.6A); however, it effectively depleted NK1.1+ cells for at least 42 h after PH (Figure 
2.6A and B). Detection of BrdU incorporation in regenerating hepatocytes revealed fewer 
BrdU+ nuclei in TCDD-treated mice that were administered either PBS or α-ASGM-1 
(Figure 2.6C). Levels of hepatocyte proliferation were similar in vehicle-treated mice 
injected with either PBS or α-ASGM-1 (Figure 2.6D). Moreover, TCDD treatment 
markedly reduced hepatocyte proliferation in both PBS- and α-ASGM-1-treated mice, 
which indicates that NK cells are dispensable for the TCDD-mediated suppression of 
liver regeneration.   
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Figure 3.6 TCDD Treatment Suppresses Liver Regeneration in Mice Depleted of 
NK Cells. To deplete NK cells, mice were treated with PBS or α-ASGM-1 antibody prior 
to administration of TCDD and surgical PH. A) Representative FACS histograms 
showing the effective depletion of intrahepatic NK cells (region "P2") in mice treated 
with α-ASGM-1 compared to PBS-treated mice. Treatment with α-ASGM-1 did not alter 
the percentage of CD3+ T cells (region "R2") or NKT cells (region "P1").  B) Average 
percentage of intrahepatic NK cells (± SEM) in PBS- and α-ASGM-1-treated mice (n=3-
6). C) Representative photomicrographs (400X) of BrdU+ nuclei in liver tissue 42 h post-
PH. D) Average percentage of BrdU+ nuclei (± SEM) in liver tissue (n=3-6). 
*Significantly different compared to vehicle-treated mice at same time point (p ≤ 0.05). 
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CHAPTER IV: DISCUSSION 
 
Increasing evidence demonstrates a physiological role for the AhR in regulating 
hepatocyte cell cycle progression (Marlowe & Puga, 2005). The murine model of PH-
induced liver regeneration provides a means to investigate AhR-mediated cell cycle 
control in non-transformed hepatocytes in vivo.  During liver regeneration, hepatocyte 
proliferation is tightly regulated by the coordinated expression of cytokines and growth 
factors (Taub, 2004).  Production of these soluble mediators represents a confounding 
variable in understanding how AhR activity regulates in vivo cell cycle progression, as 
TCDD treatment may suppress proliferation through direct effects on hepatocytes, as well 
as by modulating cytokine production by other cells in the liver. In this thesis, we 
investigated the ramifications of TCDD exposure on one of these soluble mediators, IFN-
γ, to determine its involvement in AhR-mediated cell cycle control during liver 
regeneration.   
The possibility that IFN-γ could contribute to the TCDD-induced cell cycle arrest 
in regenerating hepatocytes is compelling because this cytokine inhibits DNA synthesis 
in freshly isolated hepatoctyes and in several hepatoma-derived cell lines (Detjen et al., 
2003; Kano, Watanabe, Takeda, Aizawa, & Akaike, 1997). Furthermore, during PH-
induced liver regeneration, hepatocyte proliferation is enhanced in IFN-γ and IFNGR 
knockout mice (Sun & Gao, 2004).  Our results indicate that intrahepatic lymphocytes 
increase IFN-γ production 36 and 42 h after PH, which is consistent with other reports 
(Sun & Gao, 2004; Sun et al., 2006).  
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Results from this thesis suggest that IFN-γ is produced not only by NK cells in the 
liver, but also by NKT and CD3+ T cells (Fig 3.5). Whereas, NK cells have been reported 
elsewhere to comprise nearly all of the IFN-γ+ cells in the liver at this same time after PH 
(Sun & Gao, 2004). If NKT and CD3+ T cells are major sources of IFN-γ, then this could 
explain why depletion of NK cells failed to increase hepatocyte proliferation as we had 
expected (Figure 3.6). NKT cells are indeed capable of producing IFN-γ and may 
regulate liver regeneration under certain conditions, such as infection with hepatitis B 
virus (HBV). For instance, in HBV-tg mice, impaired liver regeneration coincided with 
an accumulation of activated, IFN-γ-producing NKT cells in the liver and was rectified 
when NKT cells were depleted (Dong et al., 2007). Hence, while NK cells are an 
important source of IFN-γ during PH-induced regeneration, data from this thesis suggest 
that the contribution of IFN-γ-producing NKT and CD3+ T cells may warrant further 
investigation. 
Contrary to our hypothesis, exposure to TCDD did not alter the magnitude or 
duration of IFN-γ production by NK cells in the regenerating liver, nor did it modulate 
IFN-γ production by NKT cells or T cells. Exposure to TCDD has been shown in other 
model systems to modulate IFN-γ production. For example, during murine infection with 
influenza virus, TCDD treatment increased IFN-γ levels in the lung (Knutson et al., 
2003). While this coincided with enhanced numbers of NK cells in the lung, increased 
IFN-γ levels were attributed to macrophage and neutrophil populations, rather than NK 
cells (Neff-LaFord et al., 2007). In contrast to several other cytokine genes, the murine 
gene encoding IFN-γ does not contain a canonical DRE, which supports speculation that 
changes in IFN-γ expression may result from dysregulated leukocyte activation and are 
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probably not the direct result of AhR-mediated changes in IFN-γ gene transcription 
(Kerkvliet, 2009).  
Generally speaking, the consequences of TCDD treatment on NK cell activation 
are inconsistent, with reports that TCDD can suppress (X. H. Wang et al., 2009) or 
enhance (Funseth & Ilback, 1992) splenic NK cell activity. Both splenic and hepatic NK 
cells reportedly display cytotoxicity against regenerating hepatocytes (Itoh, Abo, 
Sugawara, Kanno, & Kumagai, 1988; Ohnishi et al., 1993). However, we did not measure 
cytotoxicity as an endpoint of NK cell activation because it was previously reported that 
TCDD treatment did not induce appreciable levels of apoptosis in the regenerating liver 
(Mitchell et al., 2006). Nevertheless, we did measure the expression of the early 
activation marker, CD69, on lymphocytes in the regenerating liver (Figure 3.4). While 
the number of CD69+ intrahepatic lymphocytes increased after PH, exposure to TCDD 
did not alter this trend. Hence, TCDD does not appear to increase the activation of 
lymphocytes in the regenerating liver. 
Exposure to TCDD reduced the number of NKT cells in the regenerating liver 42 
h after PH. Mechanisms by which NKT cells, as well as NK cells, accumulate in the liver 
are poorly understood (Gao, Radaeva, & Park, 2009). NKT cells accumulate in the liver 
during numerous stress-related conditions, including PH-induced liver regeneration 
(Minagawa et al., 2000). However, NKT cell numbers in the liver decrease under other 
conditions, such as during bacterial infection and when NKT cells are activated by 
Concanavalin A or α-galactosylceramide (Biburger & Tiegs, 2005; Kim et al., 2008; 
Takeda et al., 2000). The liver has been shown to regulate the depletion and repopulation 
of NKT cells through different mechanisms depending on the conditions under which 
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NKT cells are activated (Subleski, Wiltrout, & Weiss, 2009). Understanding how the 
liver regulates the fate of activated NKT cells may shed light on why numbers of these 
lymphocytes are diminished in TCDD-treated mice.  However, it is worth mentioning 
that reduced numbers of NKT cells were detected in TCDD-exposed mice 42 h after PH, 
whereas hepatocyte proliferation in these mice was reduced as early as 36 h after PH. 
Hence, we question the mechanistic relevance of reduced NKT cell numbers to the 
suppression of hepatocyte proliferation in TCDD-treated mice. An alternative explanation 
is that, as a result of diminished regeneration, the liver in TCDD-treated mice enhances 
NKT cell depletion in order to restore proliferation rates in the remnant liver.  Indeed, 
previous reports indicate that activated NKT cells suppress liver regeneration (Gao et al., 
2009); hence, depleting these cells from the liver of TCDD-treated mice may represent a 
compensatory response to restore optimal hepatocyte proliferation.  
Results from this thesis indicate that spleen cellularity increases after PH.  TCDD 
treatment induced a notable trend toward decreased spleen cellularity in TCDD-treated 
mice, although it was not statistically significant. TCDD treatment correlates with 
decreased spleen cellularity in other model systems, where it likely reflects the 
suppressive effects of TCDD on the clonal expansion of splenic lymphocytes (Kerkvliet, 
2002). An alternative explanation for decreased spleen cellularity during liver 
regeneration in TCDD-treated mice is the accelerated evacuation of lymphocytes that 
could migrate to the liver (Twilley, Mason, Talmadge, & Wiltrout, 1987). However, this 
possibility is unlikely because we found that TCDD treatment failed to enhance 
recruitment of lymphocytes to the regenerating liver.  
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  In conclusion, results from this study indicate that the TCDD-mediated 
suppression of hepatocyte proliferation during liver regeneration does not require NK 
cells and most likely does not involve changes in IFN-γ production. It remains feasible 
that exposure to TCDD modulates the production of other soluble mediators that initiate 
or terminate liver regeneration. Future considerations should include distinguishing 
between direct effects of TCDD on regenerating hepatocytes and indirect effects on non-
parenchymal cells that produce regulatory cytokines and growth factors.   
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CHAPTER V: SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS 
Summary 
The overarching goal of the studies in this thesis was to identify a mechanism for 
the attenuation of liver regeneration resulting from TCDD treatment. We showed that 
TCDD attenuates liver regeneration at 36 and 42 h after PH, corroborating previous 
findings (Mitchell et al., 2006). NK cells and IFN-γ reportedly act as negative regulators 
of hepatocyte proliferation during liver regeneration  (Sun & Gao, 2004). Additionally, T 
cells and NKT cells may regulate liver regeneration as they have been shown to produce 
IFN-γ in other models of liver injury (Otani et al., 1999). In fact, NKT cells have been 
reported to increase in propensity and activity during liver regeneration after PH 
(Minagawa et al., 2000). Hence, multiple components of the innate immune system may 
contribute to the immunoregulation of liver regeneration.  Given that TCDD modulates a 
wide array of immune functions, including the production of IFN-γ, in other model 
systems (Kerkvliet, 2009), we sought to determine if alterations in the innate immune 
system could explain the suppression of liver regeneration observed in TCDD-exposed 
mice.  We hypothesized that TCDD treatment attenuates liver regeneration by increasing 
the number and activation of NK cells while also enhancing IFN-γ production in the 
regenerating liver. Furthermore, we considered the possibility that modulation of NKT 
and T cells could contribute to the TCDD-dependent inhibition of liver regeneration. 
38 
 
 
 
TCDD Treatment Does Not Increase the Number of Lymphocytes in the Spleen or Liver 
after PH 
To determine if TCDD treatment modulates the number of lymphocytes during 
liver regeneration, we analyzed NK, NKT, and T cells from the spleen and liver at 
various time points following PH. According to our analysis, while numbers of 
lymphocyte subpopulations increased after PH, TCDD generally did not alter the number 
of NK, NKT, or T cells in the liver or spleen during liver regeneration. The one exception 
to this trend was at 42 h after PH, when TCDD treatment significantly decreased the 
number of NKT cells in the liver. However, it is unlikely that this decrease contributes to 
the TCDD-induced attenuation of liver regeneration because attenuation begins at 36 h 
after PH, before any changes in NKT cell numbers are detected. Furthermore, decreased 
numbers of NKT cells would be expected to accelerate liver regeneration, which was not 
observed 42 h after PH in TCDD-treated mice.   
TCDD Treatment Does Not Increase the Number of Activated Lymphocytes in the Liver 
after PH 
To determine if TCDD treatment increases the activation of lymphocytes in the 
regenerating liver, we considered the expression of the early activation marker, CD69, on 
NK, NKT, and T cells in the liver after PH. According to our analysis, while the number 
of CD69+ lymphocytes in the liver increased after PH, TCDD treatment did not alter this 
trend. Thus, TCDD does not appear to increase the activation of NK, NKT, or T cells in 
the regenerating liver. 
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TCDD Treatment Does Not Augment the Production of IFN-γ in the Liver after PH 
To determine if TCDD treatment augments the production of IFN-γ in the 
regenerating liver, we analyzed changes in the number of IFN-γ+ NK, NKT, and T cells 
in the liver at various time points following PH. According to our analysis, the number of 
IFN-γ+ lymphocytes increased after PH.  However, TCDD treatment generally did not 
alter the number of IFN-γ+ NK, NKT, or T cells in the regenerating liver. The one 
exception to this trend was again at 42 h after PH, when TCDD treatment decreased the 
number of IFN-γ+ NKT cells in the liver. However, this is again contrary to our 
hypothesis, as we would expect that decreased numbers of IFN-γ-producing cells would 
result in accelerated liver regeneration, which was not observed 42 h after PH in TCDD-
treated mice. 
Depletion of NK Cells Has No Effect on TCDD-Induced Attenuation of Liver 
Regeneration 
To determine if NK cells are required for TCDD-induced attenuation of liver 
regeneration, we depleted NK cells in mice using an α-ASGM-1 antibody and carried out 
a typical time course experiment with TCDD and vehicle treatments followed by PH. A 
BrdU pulse was administered two hours prior to euthanasia, and liver tissue was 
processed for immunohistochemistry and stained for BrdU+ nuclei. Using this technique, 
we discovered that TCDD attenuated liver regeneration at 36 and 42 h after PH despite 
the absence of NK cells. Thus, NK cells do not play a vital role in TCDD-induced 
attenuation of liver regeneration. 
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Conclusions and Future Directions 
Contrary to our hypothesis, TCDD treatment does not exert its anti-proliferative 
effects on hepatocytes during liver regeneration by enhancing NK cell activation or 
increasing IFN-γ production. There are other possible targets of TCDD toxicity that may 
be involved in inhibiting hepatocyte proliferation after PH. In particular, one recent report 
indicates that the AhR interacts with cell cycle regulatory proteins CDK4 and cyclin D1 
to promote the progression of cells from G1 to S phase of the cell cycle, and that this 
interaction is abolished by TCDD treatment (Barhoover et al., 2010). It is possible that 
TCDD treatment renders the AhR inaccessible as a binding partner to CDK4 and cyclin 
D1. This could conceivably result in a G1 cell cycle arrest, halting proliferation. 
Furthermore, the AhR has been shown to interact with other cell cycle regulatory 
proteins, such as retinoblastoma protein (Ge & Elferink, 1998).  This raises the distinct 
possibility that the anti-proliferative effects of TCDD during liver regeneration are due to 
direct effects of TCD on hepatocytes, rather than on cells in the immune system.  Future 
studies should consider the potential interaction of the AhR with cell cycle regulatory 
proteins to determine if TCDD elicits a G1 cell cycle arrest by disrupting protein-protein 
interactions that are essential for optimal cell cycle progression. 
Our original hypothesis was predicated upon studies that identified NK cells as 
the primary producers of IFN-γ in the regenerating liver (Sun & Gao, 2004). Moreover, 
these reports also asserted that IFN-γ is responsible for negatively regulating liver 
regeneration  (Sun et al., 2006). These studies reported that livers of partially 
hepatectomized mice displayed augmented hepatocyte proliferation following depletion 
of NK cells or knockdown of the IFN-γ receptor (Sun & Gao, 2004). However, we found 
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that NK, NKT, and T cells, along with other lymphocytes, all produce significant 
amounts of IFN-γ in the liver after PH. Moreover, we found that NKT cells, not NK cells, 
represent the highest percentage of IFN-γ+ lymphocytes in the regenerating liver. This 
finding aligns with other recent studies that emphasize the importance of NKT cells in 
negatively regulating liver regeneration (Minagawa et al., 2000). We found that depletion 
of NK cells did not alter the proliferation of hepatocytes in the regenerating liver. Finally, 
although we attempted to measure changes in IFN-γ levels in liver tissue and plasma 
during liver regeneration by employing a variety of methods (Western blot, RT-PCR, 
immunofluorescence, ELISA, and cytokine bead array), IFN-γ detection proved to be 
elusive. These observations indicate that circulating and hepatic IFN-γ levels remain 
extremely low after PH and cause us to reconsider the physiological relevance of IFN-γ 
as a negative regulator of hepatocyte proliferation in the regenerating liver. Taken 
together, these findings indicate that future studies should aim to reconsider the source 
and importance of IFN-γ in the liver after PH, while also continuing to hone in on the 
overall role of the innate immune system in the regenerating liver.   
 
 
 
 
 
 
 
 
 
42 
 
 
 
 
 
 
 
 
REFERENCES 
 
Abbott, B. D., & Birnbaum, L. S. (1991). TCDD exposure of human embryonic palatal 
shelves in organ-culture alters the differentiation of medial epithelial-cells. 
Teratology, 43(2), 119-132.  
 
Alberts, B. (2010). Essential cell biology. New York; London: Garland Science. 
 
Albrecht, J. H., Poon, R. Y., Ahonen, C. L., Rieland, B. M., Deng, C., & Crary, G. S. 
(1998). Involvement of p21 and p27 in the regulation of CDK activity and cell 
cycle progression in the regenerating liver. Oncogene, 16(16), 2141-2150.  
 
Barhoover, M. A., Hall, J. M., Greenlee, W. F., & Thomas, R. S. (2010). Aryl 
hydrocarbon receptor regulates cell cycle progression in human breast cancer cells 
via a functional interaction with cyclin-dependent kinase 4. Molecular 
Pharmacology, 77(2), 195-201.  
 
Bendelac, A., Savage, P. B., & Teyton, L. (2007). The biology of NKT cells. Annual 
Review of Immunology, 25, 297-336.  
 
Benson, J. M., & Shepherd, D. M. (2011). Aryl hydrocarbon receptor activation by 
TCDD reduces inflammation associated with crohn's disease. Toxicological 
Sciences, 120(1), 68-78.  
 
Biburger, M., & Tiegs, G. (2005). Alpha-galactosylceramide-induced liver injury in mice 
is mediated by TNF-alpha but independent of Kupffer cells. Journal of 
Immunology, 175(3), 1540-1550.  
 
Biegel, L., & Safe, S. (1990). Effects of 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) 
on cell-growth and the secretion of the estrogen-induced 34-kDa, 52-kDa and 
160-kDa proteins in human breast-cancer cells. Journal of Steroid Biochemistry 
and Molecular Biology, 37(5), 725-732.  
 
Billiau, A., & Matthys, P. (2009). Interferon-gamma: a historical perspective. Cytokine & 
Growth Factor Reviews, 20(2), 97-113.  
 
Bunger, M. K., Glover, E., Moran, S. M., Walisser, J. A., Lahvis, G. P., Hsu, E. L., & 
Bradfield, C. A. (2008). Abnormal liver development and resistance to 2,3,7,8-
tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-
binding domain of the aryl hydrocarbon receptor. Toxicological Sciences, 106(1), 
83-92.  
43 
 
 
 
 
Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., & 
Bradfield, C. A. (2003). Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity 
and abnormal liver development in mice carrying a mutation in the nuclear 
localization sequence of the aryl hydrocarbon receptor. Journal of Biologicial 
Chemistry, 278(20), 17767-17774.  
 
Carver, L. A., & Bradfield, C. A. (1997). Ligand-dependent interaction of the aryl 
hydrocarbon receptor with a novel immunophilin homolog in vivo. Journal of 
Biological Chemistry, 272(17), 11452-11456.  
 
Chastain, J. E., & Pazdernik, T. L. (1985). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-
induced immunotoxicity. International Journal of Immunopharmacology, 7(6), 
849-856.  
 
Chen, H. S., & Perdew, G. H. (1994). Subunit composition of the heteromeric cytosolic 
aryl-hydrocarbon receptor complex. Journal of Biological Chemistry, 269(44), 
27554-27558.  
 
Crispe, I. N. (2009). The liver as a lymphoid organ. Annual Review of Immunology, 27, 
147-163.  
 
Cummings, J. B., Korb, B. R., & Evans, T. (1987). Assessment of 2,3,7,8-TCDD 
contamination at 2,4,5-trichlorophenol production and manufacturing use 
facilities and associated waste-disposal sites. Chemosphere, 16(8-9), 2175-2182.  
 
Detjen, K. M., Murphy, D., Welzel, M., Farwig, K., Wiedenmann, B., & Rosewicz, S. 
(2003). Downregulation of p21(waf/cip-1) mediates apoptosis of human 
hepatocellular carcinoma cells in response to interferon-gamma. Experimental 
Cell Research, 282(2), 78-89.  
 
Dong, Z., Wei, H., Sun, R., & Tian, Z. (2007). The roles of innate immune cells in liver 
injury and regeneration. Cellular and Molecular Immunology, 4(4), 241-252.  
 
Dong, Z., Zhang, J., Sun, R., Wei, H., & Tian, Z. (2007). Impairment of liver 
regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. 
Hepatology, 45(6), 1400-1412. 
 
Dugan, C. M., Fullerton, A. M., Roth, R. A., & Ganey, P. E. (2011). Natural killer cells 
mediate severe liver injury in a murine model of halothane hepatitis.  
Toxicological Sciences, 120(2), 507-518.  
 
Elferink, C. J., Gasiewicz, T. A., & Whitlock, J. P. (1990). Protein-DNA interactions at a 
dioxin-responsive enhancer - evidence that the transformed Ah receptor is 
heteromeric. Journal of Biological Chemistry, 265(33), 20708-20712.  
 
44 
 
 
 
Enan, E., & Matsumura, F. (1996). Identification of c-Src as the integral component of 
the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation 
pathway. Biochemical Pharmacology, 52(10), 1599-1612.  
 
Farrar, M. A., & Schreiber, R. D. (1993). The molecular cell biology of interferon-
gamma and its receptor. Annual Review of Immunology, 11, 571-611.  
 
Fausto, N., Campbell, J. S., & Riehle, K. J. (2006). Liver regeneration. Hepatology, 
43(2), S45-S53.  
 
Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. 
(1996). Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-
tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicology and Applied 
Pharmacology, 140(1), 173-179.  
 
Freeman, R. A., Hileman, F. D., & Schroy, J. M. (1986). Experiments on the mobility of 
TCDD at Times Beach, Missouri. Abstracts of Papers of the American Chemical 
Society, 191, 46-ENVR. 
 
Fuji-Kuriyama, Y., & Kawajiri, K. (2010). Molecular mechanisms of the physiological 
functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator 
that senses and responds to environmental stimuli. Proceedings of the Japan 
Academy Series a-Mathematical Sciences, 86(1), 40-53.  
 
Fukunaga, B. N., Probst, M. R., Reiszporszasz, S., & Hankinson, O. (1995). 
Identification of functional domains of the aryl-hydrocarbon receptor. Journal of 
Biological Chemistry, 270(49), 29270-29278.  
 
Funseth, E., & Ilback, N. G. (1992). Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin) 
increases blood and spleen natural-killer-cell activity in the mouse. Chemosphere, 
25(7-10), 917-921.  
 
Gao, B., Jeong, W. I., & Tian, Z. (2008). Liver: An organ with predominant innate 
immunity. Hepatology, 47(2), 729-736.  
 
Gao, B., Radaeva, S., & Park, O. (2009). Liver natural killer and natural killer T cells: 
immunobiology and emerging roles in liver diseases. Journal of Leukocyte 
Biology, 86(3), 513-528.  
 
Gasiewicz, T. A., Elferink, C. J., & Henry, E. C. (1991). Characterization of multiple 
forms of the Ah receptor - recognition of a dioxin-responsive enhancer involves 
heteromer formation. Biochemistry, 30(11), 2909-2916.  
 
45 
 
 
 
Ge, N., & Elferink, C. (1998). A direct interaction between the aryl hydrocarbon receptor 
and retinoblastoma protein. Linking dioxin signaling to the cell cycle. Journal of 
Biological Chemistry, 273(35), 22708-22713. 
 
Goldsby, R. A., Kindt, T. J., Osborne, B. A., & Kuby, J. (2000). Kuby immunology. New 
York: W.H. Freeman. 
 
Gottlicher, M., & Wiebel, F. J. (1991). 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes 
unbalanced growth in 5L rat hepatoma cells. Toxicol Appl Pharmacol, 111(3), 
496-503.  
 
Hanberg, A., Hakansson, H., & Ahlborg, U. G. (1989). ED50 values for TCDD-induced 
reduction OF body-weight gain, liver enlargement, and thymic atrophy in hartley 
guinea-pigs, sprague-dawley rats, C57BL6 mice, and golden syrian-hamsters. 
Chemosphere, 19(1-6), 813-816.  
 
Harper, P. A., Prokipcak, R. D., Bush, L. E., Golas, C. L., & Okey, A. B. (1991). 
Detection and characterization of the Ah-receptor for 2,3,7,8-tetrachlorodibenzo-
p-dioxin in the human colon adenocarcinoma cell-line LS180. Archives of 
Biochemistry and Biophysics, 290(1), 27-36.  
 
Harstad, E. B., Guite, C. A., Thomae, T. L., & Bradfield, C. A. (2006). Liver deformation 
in Ahr-null mice: evidence for aberrant hepatic perfusion in early development. 
Molecular Pharmacology, 69(5), 1534-1541. 
 
 Henry, E. C., & Gasiewicz, T. A. (1993). Transformation of the aryl-hydrocarbon 
receptor to a DNA-binding form is accompanied by release of the 90-kDa heat-
shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin. 
Biochemical Journal, 294, 95-101.  
 
Huff, J. (1992). 2,3,7,8-TCDD - A potent and complete carcinogen in experimental-
animals. Chemosphere, 25(1-2), 173-176.  
 
Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Thierfelder, W. E., Kreider, 
B., & Silvennoinen, O. (1994). Signaling by the cytokine receptor superfamily - 
JAKs and STATs. Trends in Biochemical Sciences, 19(5), 222-227.  
 
Ikuta, T., Eguchi, H., Tachibana, T., Yoneda, Y., & Kawajiri, K. (1998). Nuclear 
localization and export signals of the human aryl hydrocarbon receptor. Journal of 
Biological Chemistry, 273(5), 2895-2904.  
 
Itoh, H., Abo, T., Sugawara, S., Kanno, A., & Kumagai, K. (1988). Age-related variation 
in the proportion and activity of murine liver natural-killer cells and their cyto-
toxicity against regenerating hepatocytes. Journal of Immunology, 141(1), 315-
323.  
 
46 
 
 
 
Jin, D. Q., Jung, J. W., Lee, Y. S., & Kim, J. A. (2004). 2,3,7,8-tetrachlorodibenzo-p-
dioxin inhibits cell proliferation through arylhydrocarbon receptor-mediated G(1) 
arrest in SK-N-SH human neuronal cells. Neuroscience Letters, 363(1), 69-72. 
 
Kano, A., Watanabe, Y., Takeda, N., Aizawa, S., & Akaike, T. (1997). Analysis of IFN-
gamma-induced cell cycle arrest and cell death in hepatocytes. Journal of 
Biochemistry, 121(4), 677-683.  
 
Kao, C. M., Chen, S. C., Liu, J. K., & Wu, M. J. (2001). Evaluation of TCDD 
biodegradability under different redox conditions. Chemosphere, 44(6), 1447-
1454.  
 
Kerkvliet, N. I. (2002). Recent advances in understanding the mechanisms of TCDD 
immunotoxicity. International Immunopharmacology, 2(2-3), 277-291.  
 
Kerkvliet, N. I. (2009). AHR-mediated immunomodulation: the role of altered gene 
transcription. Biochem Pharmacol, 77(4), 746-760.  
 
Kim, S., Lalani, S., Parekh, V. V., Vincent, T. L., Wu, L., & Van Kaer, L. (2008). Impact 
of bacteria on the phenotype, functions, and therapeutic activities of invariant 
NKT cells in mice. Journal of Clinical Investigation, 118(6), 2301-2315.  
 
Knutson, M., Neff-LaFord, H. D., & Lawrence, B. P. (2003). Characterizing the effects 
of dioxin on the production of interferon-gamma in the lung of influenza-infected 
mice. Faseb Journal, 17(7), C280.  
 
Kolluri, S. K., Weiss, C., Koff, A., & Gottlicher, M. (1999). p27(Kip1) induction and 
inhibition of proliferation by the intracellular Ah receptor in developing thymus 
and hepatoma cells. Genes & Development, 13(13), 1742-1753.  
 
Komita, H., Homma, S., Saotome, H., Zeniya, M., Ohno, T., & Toda, G. (2006). 
Interferon-gamma produced by interleukin-12-activated tumor infiltrating 
CD8(+)T cells directly induces apoptosis of mouse hepatocellular carcinoma. 
Journal of Hepatology, 45(5), 662-672.  
 
Lai, H. S., Chen, W. J., & Chen, K. M. (1996). Changes in T-lymphocyte subpopulations 
and serum lymphokine concentrations after partial hepatectomy in rats. Nutrition, 
12(10), 700-705.  
 
Laiosa, M. D., Wyman, A., Murante, F. G., Fiore, N. C., Staples, J. E., Gasiewicz, T. A., 
& Silverstone, A. E. (2003). Cell proliferation arrest within intrathymic 
lymphocyte progenitor cells causes thymic atrophy mediated by the aryl 
hydrocarbon receptor. Journal of Immunology, 171(9), 4582-4591.  
 
 
47 
 
 
 
Lakshman, M. R., Campbell, B. S., Chirtel, S. J., & Ekarohita, N. (1985). Absorption, 
distribution and metabolism of 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD), 
the toxic contaminant of Agent Orange. Federation Proceedings, 44(4), 1117-
1117.  
 
Lebel, G. L., Williams, D. T., & Benoit, F. M. (1992). Chlorinated dibenzodioxins and 
dibenzofurans in consumer paper products. Chemosphere, 25(11), 1683-1690.  
 
Lusska, A., Shen, E., & Whitlock, J. P. (1993). Protein-DNA interactions at a dioxin-
responsive enhancer - analysis of 6 bona-fide DNA-binding sites for the liganded 
Ah receptor. Journal of Biological Chemistry, 268(9), 6575-6580.  
 
Ma, Q. (2001). Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor 
regulation, and expanding biological roles. Current Drug Metabolism, 2(2), 149-
164.  
 
Ma, Q., & Whitlock, J. P. (1996). The aromatic hydrocarbon receptor modulates the Hepa 
1c1c7 cell cycle and differentiated state independently of dioxin. Molecular and 
Cellular Biology, 16(5), 2144-2150.  
 
Mandal, P. K. (2005). Dioxin: a review of its environmental effects and its aryl 
hydrocarbon receptor biology. Journal of Comparative Physiology, 175(4), 221-
230.  
 
Mangnall, D., Bird, N. C., & Majeed, A. W. (2003). The molecular physiology of liver 
regeneration following partial hepatectomy. Liver International, 23(2), 124-138.  
 
Marlowe, J. L., & Puga, A. (2005). Aryl hydrocarbon receptor, cell cycle regulation, 
toxicity, and tumorigenesis. Journal of Cellular Biochemistry, 96(6), 1174-1184.  
 
Michalopoulos, G. K. (2007). Liver regeneration. Journal of Cellular Physiology, 213(2), 
286-300.  
 
Michalopoulos, G. K. (2010). Liver regeneration after partial hepatectomy: critical 
analysis of mechanistic dilemmas. American Journal of Pathology, 176(1), 2-13.  
 
Minagawa, M., Oya, H., Yamamoto, S., Shimizu, T., Bannai, M., Kawamura, H., Abo, T. 
(2000). Intensive expansion of natural killer T cells in the early phase of 
hepatocyte regeneration after partial hepatectomy in mice and its association with 
sympathetic nerve activation. Hepatology, 31(4), 907-915.  
 
Miniero, R., De Felip, E., Ferri, F., & di Domenico, A. (2001). An overview of TCDD 
half-life in mammals and its correlation to body weight. Chemosphere, 43(4-7), 
839-844.  
 
48 
 
 
 
Mitchell, K. A., & Elferink, C. J. (2009). Timing is everything: Consequences of 
transient and sustained AhR activity. Biochemical Pharmacology, 77(6), 947-956.  
 
Mitchell, K. A., Lockhart, C. A., Huang, G., & Elferink, C. J. (2006). Sustained aryl 
hydrocarbon receptor activity attenuates liver regeneration. Molecular 
Pharmacology, 70(1), 163-170. 
  
Miyagi, T., Takehara, T., Tatsumi, T., Suzuki, T., Jinushi, M., Kanazawa, Y., Hayashi, N. 
(2004). Concanavalin A injection activates intrahepatic innate immune cells to 
provoke an antitumor effect in murine liver. Hepatology, 40(5), 1190-1196. 
 
Mukerjee, D. (1998). Health impact of polychlorinated dibenzo-p-dioxins: a critical 
review. Journal of the Air & Waste Management Association, 48(2), 157-165.  
 
Nagao, M., Nakajima, Y., Kanehiro, H., Hisanaga, M., Aomatsu, Y., Ko, S., Nakano, H. 
(2000). The impact of interferon gamma receptor expression on the mechanism of 
escape from host immune surveillance in hepatocellular carcinoma. Hepatology, 
32(3), 491-500.  
 
Neff-LaFord, H., Teske, S., Bushnell, T. P., & Lawrence, B. P. (2007). Aryl hydrocarbon 
receptor activation during influenza virus infection unveils a novel pathway of 
IFN-gamma production by phagocytic cells. Journal of Immunology, 179(1), 247-
255.  
 
Neubert, D., Krowke, R., Chahoud, I., & Franz, G. (1987). Studies on the reproductive 
toxicity of 2,3,7,8-TCDD in rodents and nonhuman-primates. Teratology, 35(2), 
A66.  
 
Ochi, M., Ohdan, H., Mitsuta, H., Onoe, T., Tokita, D., Hara, H., Asahara, T. (2004). 
Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. 
Hepatology, 39(5), 1321-1331.  
 
Ohnishi, H., Muto, Y., Maeda, T., Hayashi, T., Nagaki, M., Yamada, T., Moriwaki, H. 
(1993). Natural killer cell may impair liver regeneration in fulminant hepatic 
failure. Gastroenterology Japan, 28 Suppl 4, 40-44; discussion 53-46.  
 
Otani, T., Nakamura, S., Toki, M., Motoda, R., Kurimoto, M., & Orita, K. (1999). 
Identification of IFN-gamma-producing cells in IL-12/IL-18-treated mice. 
Cellular Immunology, 198(2), 111-119.  
 
Pohjanvirta, R., Unkila, M., & Tuomisto, J. (1994). TCDD-induced hypophagia is not 
exlpained by nausea. Pharmacology Biochemistry and Behavior, 47(2), 273-282.  
 
Poland, A., & Knutson, J. C. (1982). 2,3,7,8-tetrachlorodibenzo-para-dioxin and related 
halogenated aromatic-hydrocarbons - examination of the mechanism of toxicity. 
Annual Review of Pharmacology and Toxicology, 22, 517-554.  
49 
 
 
 
Prell, R. A., Oughton, J. A., & Kerkvliet, N. I. (1995). Effect of 2,3,7,8-
tetrachlorodibenzo-p-dioxin on anti-CD3-induced chances in T-cell subsets and 
cytokine production. International Journal of Immunopharmacology, 17(11), 951-
961.  
 
Racanelli, V., & Rehermann, B. (2006). The liver as an immunological organ. 
Hepatology, 43(2 Suppl 1), S54-62.  
 
Ray, S. S., & Swanson, H. I. (2003). Alteration of keratinocyte differentiation and 
senescence by the tumor promoter dioxin. Toxicology and Applied Pharmacology, 
192(2), 131-145.  
 
Reggiani, G. (1978). Medical problems raised by TCDD contamination in Seveso, Italy. 
Archives of Toxicology, 40(3), 161-188.  
 
Reiners, J. J., Clift, R., & Mathieu, P. (1999). Suppression of cell cycle progression by 
flavonoids: dependence on the aryl hydrocarbon receptor. Carcinogenesis, 20(8), 
1561-1566.  
 
Rozman, K. (1984). Hexadecane increases the toxicity of 2,3,7,8-tetrachlorodibenzo-
para-dioxin (TCDD) - is brown adipose-tissue the primary target in TCDD-
induced wasting syndrome. Biochemical and Biophysical Research 
Communications, 125(3), 996-1004.  
 
Safe, S. (2001). Molecular biology of the Ah receptor and its role in carcinogenesis. 
Toxicology Letters, 120(1-3), 1-7.  
 
Savouret, J. F., Berdeaux, A., & Casper, R. F. (2003). The aryl hydrocarbon receptor and 
its xenobiotic ligands: a fundamental trigger for cardiovascular diseases. Nutrition 
and Metabolic Cardiovascular Disease, 13(2), 104-113.  
 
Schecter, A., & Gasiewicz, T. A. (2003). Dioxins and Health (2nd ed.). Hoboken, NJ: 
John Wiley and Sons, Inc. 
 
Schmidt, J. V., Su, G. H. T., Reddy, J. K., Simon, M. C., & Bradfield, C. A. (1996). 
Characterization of a murine Ahr null allele: Involvement of the Ah receptor in 
hepatic growth and development. Proceedings of the National Academy of 
Sciences of the United States of America, 93(13), 6731-6736.  
 
Shen, E. S., & Whitlock, J. P. (1992). Protein-DNA interactions at a dioxin-responsive 
enhancer - mutational analysis of the DNA-binding site for the liganded Ah 
receptor. Journal of Biological Chemistry, 267(10), 6815-6819.  
 
 
 
50 
 
 
 
Shen, K., Zheng, S. S., Park, O., Wang, H., Sun, Z., & Gao, B. (2008). Activation of 
innate immunity (NK/IFN-gamma) in rat allogeneic liver transplantation: 
contribution to liver injury and suppression of hepatocyte proliferation. American 
Journal of Physiology: Gastrointestinal Liver Physiology, 294(4), G1070-1077.  
 
Subleski, J. J., Wiltrout, R. H., & Weiss, J. M. (2009). Application of tissue-specific NK 
and NKT cell activity for tumor immunotherapy. Journal of Autoimmunity, 33(3-
4), 275-281.  
 
Sugita-Konishi, Y., Kobayashi, K., Naito, H., Miura, K., & Suzuki, Y. (2003). Effect of 
lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on the susceptibility to 
Listeria infection. Bioscience Biotechnology and Biochemistry, 67(1), 89-93.  
 
Sun, R., & Gao, B. (2004). Negative regulation of liver regeneration by innate immunity 
(natural killer cells/interferon-gamma). Gastroenterology, 127(5), 1525-1539. 
 
Sun, R., Park, O., Horiguchi, N., Kulkarni, S., Jeong, W. I., Sun, H. Y., Gao, B. (2006). 
STAT1 contributes to dsRNA inhibition of liver regeneration after partial 
hepatectomy in mice. Hepatology, 44(4), 955-966.  
 
Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H., & Okumura, K. 
(2000). Critical contribution of liver natural killer T cells to a murine model of 
hepatitis. Proceedings of the National Academy of Sciences of the United States of 
America, 97(10), 5498-5503.  
 
Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008). The IRF family 
transcription factors in immunity and oncogenesis. Annual Review of 
Immunology, 26, 535-584.  
 
Taub, R. (2004). Liver regeneration: From myth to mechanism. Nature Reviews: 
Molecular Cell Biology, 5(10), 836-847.  
 
Thornton, J., McCally, M., Orris, P., & Weinberg, J. (1996). Dioxin prevention and 
medical waste incinerators. Public Health Reports, 111(4), 298-313.  
 
Travis, C. C., & Hattemerfrey, H. A. (1991). Human exposure to dioxin. Science of the 
Total Environment, 104(1-2), 97-127.  
 
Twilley, T. A., Mason, L., Talmadge, J. E., & Wiltrout, R. H. (1987). Increase in liver-
associated natural killer activity by polyribonucleotides. Natural Immunity and 
Cell Growth Regulation, 6(6), 279-290.  
 
Valente, G., Ozmen, L., Novelli, F., Geuna, M., Palestro, G., Forni, G., & Garotta, G. 
(1992). Distribution of interferon-gamma receptor in human tissues. European 
Journal of Immunology, 22(9), 2403-2412.  
 
51 
 
 
 
Volpes, R., van den Oord, J. J., De Vos, R., Depla, E., De Ley, M., & Desmet, V. J. 
(1991). Expression of interferon-gamma receptor in normal and pathological 
human liver tissue. Journal of Hepatology, 12(2), 195-202.  
 
Vorderstrasse, B. A., Steppan, L. B., Silverstone, A. E., & Kerkvliet, N. I. (2001). Aryl 
hydrocarbon receptor-deficient mice generate normal immune responses to model 
antigens and are resistant to TCDD-induced immune suppression. Toxicology and 
Applied Pharmacology, 171(3), 157-164.  
 
Vujanovic, N. L., Polimeno, L., Azzarone, A., Francavilla, A., Chambers, W. H., Starzl, 
T. E., Whiteside, T. L. (1995). Changes of liver-resident NK cells during liver 
regeneration in rats. Journal of Immunol, 154(12), 6324-6338.  
 
Wang, J., Xu, J., Zhang, W., Wei, H., & Tian, Z. (2005). TLR3 ligand-induced 
accumulation of activated splenic natural killer cells into liver. Cellular and 
Molecular Immunology, 2, 449-453.  
 
Wang, X. H., Zhou, X. Q., Xu, J. P., Wang, Y., & Lu, J. (2009). The effects of vitamin E 
on NK cell activity and lymphocyte proliferation in treated mice by 2,3,7,8-
tetrachlorodibenzo-p-dioxin. Immunopharmacol Immunotoxicol, 31(3), 432-438.  
 
Wei, H. R., Wei, H. M., Wang, H., Tian, Z. G., & Sun, R. I. (2010). Activation of natural 
killer cells inhibits liver regeneration in toxin-induced liver injury model in mice 
via a tumor necrosis factor-alpha-dependent mechanism. American Journal of 
Physiology: Gastrointestinal and Liver Physiology, 299(1), G275-G282.  
 
White, S. S., & Birnbaum, L. S. (2009). An overview of the effects of dioxins and dioxin-
like compounds on vertebrates, as documented in human and ecological 
epidemiology. Journal of Environmental Science and Health Part C: 
Environmental Carcinogenesis & Ecotoxicology Reviews, 27(4), 197-211.  
 
Whitlock, J. P. (1999). Induction of cytochrome P4501A1. Annual Review of 
Pharmacology and Toxicology, 39, 103-125.  
 
Wolfle, D., Marotzki, S., Dartsch, D., Schafer, W., & Marquardt, H. (2000). Induction of 
cyclooxygenase expression and enhancement of malignant cell transformation by 
2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis, 21(1), 15-21.  
 
Young, A. L., Thalken, C. E., & Harrison, D. D. (1979). Persistence, bioaccumulation 
and toxicology of TCDD in an ecosystem treated with massive quantities of 2,4,5-
T herbicide. Abstracts of Papers of the American Chemical Society, Sep, 84.  
 
 
